Document is current
Any future updates will be listed below
-
Authors
Kario, Kazuomi
Ohbayashi, Hiroyuki
Hashimoto, Masami
Itabashi, Naoki
Kato, Mitsutoshi
Uchiyama, Kazuaki
Hirano, Kunio
Nakamura, Noriko
Miyamoto, Takahide
Nagashima, Hirotaka
Kajiyama, Shizuo
Ishida, Hidenori
Imai, Enyu
Ebe, Yusuke
Ohishi, Mitsuru
Katsuya, Tomohiro
Taguchi, Takashi
Tanabe, Ayumi
Shimosawa, Tatsuo
,
- License Information
-
More Information
Article History
Received: 5 April 2024
Revised: 20 May 2024
Accepted: 30 May 2024
First Online: 23 July 2024
Compliance with ethical standards
:
: Daiichi Sankyo Co., Ltd. supported all authors for medical writing, article processing charges; for research funding (except for MO, TT, AT, and TS); KK, MO, TK, and TS for advisory fee. KK received research grants from Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd, MSD K.K., Sumitomo Pharma Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd.; consulting fees from Sanwa Kagaku Kenkyusho Co., Ltd.; honoraria from Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Novartis Pharma K.K., Viatris Inc.; and is an advisory board member of Daiichi Sankyo Co., Ltd. and Novartis Pharma K.K. SK received honoraria from Daiichi Sankyo Co., Ltd. EI received honoraria from AstraZeneca K.K., Torii Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corp. TK received honoraria from Novartis Pharma K.K., Takeda Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Moderna, Inc.; payment for expert testimony from Takeda Pharmaceutical Co., Ltd., Novartis Pharma K.K., support for travel expenses from Takeda Pharmaceutical Co., Ltd., Novartis Pharma K.K., AstraZeneca K.K. TT and AT are employees of Daiichi Sankyo Co., Ltd. TS received research funding from Takenaka Co., Ltd., FUJIFILM Corp., Nippon Boehringer Ingelheim Co., Ltd., Teijin Pharma Ltd., Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd., consultant fees from Sekisui Medical Co., Ltd., EP Mediate Co., Ltd., honoraria from Novartis Pharma K.K., Taisho Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Sanofi K.K., Mochida Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Aeon Co., Ltd., FUJIFILM Corp., Otsuka Pharmaceutical Co., Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corp., Elsevier Japan K.K., Abbott Japan LLC., Eiken Chemical Co., Ltd.; is a board member of Otsuka Medical Devices Co., Ltd. and Daiichi Sankyo Co., Ltd.; is the chair of CVEM2023, deputy director and educational seminars chair of Japanese Society of Medical Use of Functional Food, and member of the steering committee of angiotensin Gordon Research Conference.
